HGF and HGF Agonists, Expression in Wound and Potential Role in the Management of Wound Healing

Author(s): Kevin Conway

Journal Name: Current Signal Transduction Therapy

Volume 6 , Issue 2 , 2011

Become EABM
Become Reviewer
Call for Editor


Hepatocyte growth factor (HGF) has been shown to have multiple effects on the wound healing process. Several in vitro and ex vivo models using HGF have been shown to promote wound healing. The expression of HGF and its receptor cMet are different in chronic and acute wounds. HGF treatments in chronic wounds have not lived up to the expectations of the in vitro and ex vivo models. This review looks at the different expression of the HGF receptor and HGF agonists in chronic wounds compared to acute wounds. This aberrant expression may have a value in identifying early the wounds at risk of becoming chronic. A greater understanding of HGF and HGF agonists expression will have a direct implication for a protein engineering approach to the management of chronic wounds.

Keywords: HGF, HGF agonists, c-Met, wound healing, Matriptase, Keratinocyte, proteolytic

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Published on: 01 March, 2012
Page: [152 - 155]
Pages: 4
DOI: 10.2174/157436211795659919
Price: $65

Article Metrics

PDF: 6